The authors investigated whether fenofibrate increased circulating hematopoietic stem/progenitor cells (HSPCs). When compared with placebo, fenofibrate significantly increased levels of HSPCs expressing CD34 and/or CD133.
[Diabetologia]
7992332
{7992332:U7KJZ6IM}
apa
50
1
165470
https://www.stemcellsciencenews.com/wp-content/plugins/zotpress/
